on 11 Jun 2024
Last Applicant/ Owned by
DK-2920 Charlottenlund
DK
Serial Number
79371712 filed on 06th Jan 2023
Registration Number
7410895 registered on 11th Jun 2024
Correspondent Address
Howard W. Kline
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Scientific research; scientific laboratory services; scientific research into stem cells; culturing of cells for scientific research purposes; scientific and medical research services for research and development in the field of immunology; pharmaceutical research; development of pharmaceutical preparations; pharmaceutical research and development services; development of pharmaceutical preparatio Read More
Scientific research; scientific laboratory services; scientific research into stem cells; culturing of cells for scientific research purposes; scientific and medical research services for research and development in the field of immunology; pharmaceutical research; development of pharmaceutical preparations; pharmaceutical research and development services; development of pharmaceutical preparations and medications; carrying out clinical trials for pharmaceutical products; laboratory research on pharmaceutical preparations; consultancy in the field of drug research and development; software as a service (SAAS) services featuring software for gathering, tracking, analyzing and activating data in relation to transformative therapies for high-risk immunocompromised patients and transplant recipients
N/A
N/A
Surgical apparatus and instruments for medical use; medical diagnostic test instruments for use in immunoanalytical procedures; medical diagnostic testing apparatus for use in medical immunoassay procedures; medical devices for regenerating stem cells for medical purposes; medical apparatus for cell sampling; pharmaceutical instruments and apparatus provided empty used for the inhalation of pharmaceuticals
N/A
N/A
Pharmaceutical preparations for the prevention of chronic viral infections in high-risk immunocompromised patients and transplant recipients; pharmaceutical preparations for regulating the immune system for high-risk immunocompromised patients and transplant recipients; pharmaceutical preparations for use in organ transplantation for elimination of chronic viral infections; pharmaceutical preparations for the prevention of diseases of the immune system; immunosuppressants for use following transplantation to prevent graft rejection; pharmaceutical preparations for the treatment of immune system related diseases and disorders; immunotherapeutic agents for treatment of bacterial infections; pharmaceutical preparations for immunity adjustment for high-risk immunocompromised patients and transplant recipients; pharmaceutical preparations containing stem cells for high-risk immunocompromised patients and transplant recipients; immunoassay reagents for medical use; pharmaceutical preparations for the treatment of viral diseases; anti-viral agents; protein synthesis inhibitors for high-risk immunocompromised patients and transplant recipients; regulatory proteins being pharmaceutical preparations for medical use for high-risk immunocompromised patients and transplant recipients; pharmaceutical drugs for high-risk immunocompromised patients and transplant recipients; antibacterial pharmaceuticals
N/A
N/A
No 79371712
No Service Mark
No 63868T
No
No
No
No
Yes
Yes
No
No
Status Date | Action Taken |
---|---|
22nd Nov 2024 | FINAL DISPOSITION PROCESSED |
22nd Nov 2024 | FINAL DISPOSITION NOTICE SENT TO IB |
11th Sep 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
11th Jun 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
11th Jun 2024 | REGISTERED-PRINCIPAL REGISTER |
26th Mar 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
26th Mar 2024 | PUBLISHED FOR OPPOSITION |
06th Mar 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
06th Mar 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
20th Feb 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |